Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C
Also known as: PDE1C
Function
Calmodulin-dependent cyclic nucleotide phosphodiesterase with a dual specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes. Has a high affinity for both cAMP and cGMP. Modulates the amplitude and duration of the cAMP signal in sensory cilia in response to odorant stimulation, hence contributing to the generation of action potentials. Regulates smooth muscle cell proliferation. Regulates the stability of growth factor receptors, including PDGFRB (Probable). In kidney juxtaglomerular granular cells, inhibits renin release by decreasing cAMP levels (By similarity).
Classification
- Family (Pfam)
- PF00233 PDEase_I, PF08499 PDEase_I_N
- InterPro
- HD/PDEase_dom, PDE1_N, PDEase, PDEase_catalytic_dom, PDEase_catalytic_dom_sf, PDEase_CS
- Functional cluster
- Protein Serine/Threonine Kinases
Gene Ontology · 11
- GO:0005829 cytosol
- GO:0005764 lysosome
- GO:0043025 neuronal cell body
- GO:0004115 3',5'-cyclic-AMP phosphodiesterase activity
- GO:0047555 3',5'-cyclic-GMP phosphodiesterase activity
- GO:0005516 calmodulin binding
- GO:0048101 calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity
- GO:0004117 calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity
- GO:0046872 metal ion binding
- GO:0141162 negative regulation of cAMP/PKA signal transduction
- GO:0007165 signal transduction
Disease associations
- hearing loss, autosomal dominant 74 MONDO:0029137
Drugs targeting this protein · 2
- PENTOXIFYLLINE inhibitor
- DIPYRIDAMOLE inhibitor
Related proteins · sequence + function similarity
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C 1.00
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C 0.98
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A 0.90
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A 0.89
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A 0.88
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B 0.86
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B 0.86
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B 0.86
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B 0.86
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B 0.85
- Probable 3',5'-cyclic phosphodiesterase pde-1 0.79
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 0.75
Co-cited proteins · studied together in the literature
Literature · 5 cited papers
- A dominant variant in the PDE1C gene is associated with nonsyndromic hearing loss. Hum. Genet. · 2018
- Large-scale proteomics analysis of the human kinome. Mol. Cell. Proteomics · 2009
- Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat. Genet. · 2004
- The DNA sequence of human chromosome 7. Nature · 2003
- Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3',5'-cyclic nucleotide phosphodiesterases. J. Biol. Chem. · 1996
A document in the lmmol reference corpus — open public data (UniProt, GO, PDB, the literature graph) rendered as a single cross-linked page. Hover any link to preview its target.